Relapsed Synovial Sarcoma: Treatment Options.
Mia C WeissBrian A Van TinePublished in: Current treatment options in oncology (2023)
Synovial sarcoma (SS) is a fusion-driven subtype of sarcoma that is a more chemo-sensitive subtype of soft tissue sarcoma. While chemotherapy options are currently standard of care, our fundamental understanding of the biology of SS is driving new therapies. We will review the current standard of care, as well as the current therapies showing promise in a clinical trial. It is our hope that by encouraging participation in clinical trials, the fundamental therapies available for SS will change the current treatment paradigm.
Keyphrases
- clinical trial
- healthcare
- palliative care
- quality improvement
- acute lymphoblastic leukemia
- phase ii
- physical activity
- locally advanced
- squamous cell carcinoma
- photodynamic therapy
- combination therapy
- diffuse large b cell lymphoma
- randomized controlled trial
- double blind
- open label
- pain management
- affordable care act
- radiation therapy
- phase iii
- machine learning
- cancer therapy
- replacement therapy